Population Pharmacokinetics of Liposomal Amphotericin B in Pediatric Patients with Malignant DiseasesYing Hong, Andrew J. McLachlan, Katherine Stephen et al.|Antimicrobial Agents and Chemotherapy|2006Cited by 102
Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapyChrista E. Nath, John Earl, Gareth Hegarty et al.|British Journal of Clinical Pharmacology|2010Cited by 80
High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantationChrista E. Nath, Peter J. Shaw, Judith Trotman et al.|British Journal of Clinical Pharmacology|2016Cited by 59
Amphotericin B in Children with Malignant Disease: a Comparison of the Toxicities and Pharmacokinetics of Amphotericin B Administered in Dextrose versus Lipid EmulsionChrista E. Nath, John Earl, Peter J. Shaw et al.|Antimicrobial Agents and Chemotherapy|1999Cited by 58
Population pharmacokinetics of amphotericin B in children with malignant diseasesChrista E. Nath, John Earl, Andrew J. McLachlan et al.|British Journal of Clinical Pharmacology|2001Cited by 41